Latest News

Wednesday, January 28, 2015 | Practice Development

Nvision Eye Centers Announce Change in Location and Leadership

After 15 years at its Newport Beach, California location, Nvision Eye Centers, one of the largest providers of LASIK and cataract surgery in the US, has moved its headquarters to the city of Aliso Vie…

Read the full story

Wednesday, January 28, 2015 | Management/Leadership, TearLab Corp.

TearLab Appoints Raymond Kong as Vice President of Sales

TearLab announced the appointment of Raymond Kong to its senior management team as vice president of sales, according to a company news release. Mr. Kong succeeds Duane Morrison, who will shift his fo…

Read the full story

Wednesday, January 28, 2015 | Blindness

Researchers Advance the Science Behind Treating Patients with Corneal Blindness

Researchers in the Cedars-Sinai Board of Governors Regenerative Medicine Institute have devised a novel way to generate transplantable corneal stem cells that may eventually benefit patients suffering…

Read the full story

Tuesday, January 27, 2015 | Miscellaneous

Living Well with Low Vision Partners with Enablemart to Support Growing Community of People with Low Vision

Visitors to Living Well with Low Vision, lowvision.preventblindness.org, will now be able to purchase low vision aids and products through Enablemart.com, a premier provider of products for people wit…

Read the full story

Tuesday, January 27, 2015 | Medical Studies

Slight Posterior Corneal Protrusion After LASIK and PRK

Femtosecond laser-assisted LASIK and photorefractive keratectomy (PRK) are both associated with mild but statistically significant forward protrusion of the posterior cornea. According to results from…

Read the full story

Tuesday, January 27, 2015 | Abbott Medical Optics

Toric Lens May Improve Astigmatism After Cataract Removal

The Tecnis IOL (Abbott Medical Optics) significantly improved vision in astigmatic eyes, sharpened uncorrected vision, and proved rotationally stable after lens implantation with cataract removal in p…

Read the full story

Tuesday, January 27, 2015 | Retina, Psivida

pSivida Reports Iluvien Receives Marketing Authorization in Two More EU Countries

pSivida Corp. announced that Finland and Luxembourg have granted marketing authorization to Iluvien for the treatment of vision impairment associated with chronic diabetic macular edema (DME) consider…

Read the full story

Tuesday, January 27, 2015 | Management/Leadership

Robert Califf, MD, Named FDA Deputy Commissioner for Medical Products and Tobacco

U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, MD, appointed Robert Califf, MD, a leader in cardiology, clinical research, and medical economics, as FDA Deputy Commissioner for Me…

Read the full story

Tuesday, January 27, 2015 | Product Releases

New Eye Scan Predicts Peripheral Neuropathy in Diabetes

Corneal confocal microscopy (CCM) predicts incipient peripheral neuropathy in patients with type 1 diabetes, a new study finds. The technique involves the examination of unmyelinated nerve fibers at h…

Read the full story

Monday, January 26, 2015 | FDA Approval/Clearance, Abbott Medical Optics

Abbott Receives FDA Clearance for the Creation of Intracorneal Pockets With the iFS Femtosecond Laser System

Abbott Medical Optics (AMO) announced FDA clearance for the creation of intracorneal pockets with the iFS Advanced Femtosecond Laser System, according to a company statement. The iFS software will all…

Read the full story

Monday, January 26, 2015 | CE Mark Approval

Neurostim Dry Eye Startup Backed by Kleiner Perkins, NEA Readies for CE Mark

Dry eye implant maker Oculeve is working toward a CE mark with its venture round from last spring. It's also in the process of recruiting for an initial U.S. clinical trial; the trial started in D…

Read the full story

Monday, January 26, 2015 | Acquisitions/Mergers, Haag Streit, Optovue

Haag-Streit UK Appointed Sole Distributor of the Optovue Portfolio in the UK

Haag-Streit UK (HS-UK) has announced that it will be appointed sole distributor of the Optovue product portfolio in the UK beginning February 4, according to a company news release. HS-UK will be taki…

Read the full story

Monday, January 26, 2015 | Retina, Bayer, Regeneron Pharmaceuticals

Eylea Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to CRVO or BRVO in the European Union

Regeneron Pharmaceuticals announced that Eylea (aflibercept) injection has been recommended for approval by the European Committee for Medicinal Products for Human Use (CHMP) for the treatment of visu…

Read the full story

Monday, January 26, 2015 | Management/Leadership

Nightstar Announces an Increased Investment to £17m and Appoints a New Chief Executive Officer

NightstaRx announced an increase in its funding to £17 million to expedite the company’s clinical choroideremia program, according to a company news release. The funding has come from the …

Read the full story

Monday, January 26, 2015 | Retina

Hanmi Invests $20M in Allegro and Licenses Its AMD, DME and VMT Therapy in Korea and China

Allegro Ophthalmics and Hanmi Pharmaceuticals have entered into a license agreement for Luminate (ALG-1001), Allegro’s Integrin Peptide Therapy, in The Republic of Korea and the People’s R…

Read the full story
Load More